Boston Scientific price target raised to $20 — 4 things to know

Boston Scientific’s price target was raised by Barclays from $19 to $20, according to a Sleek Money report.

Advertisement

Here are four things to know about the stock:

•    Boston Scientific stock has an average rating of buy.
•    The company has a one-year low of $11.10 and a one-year high of $18.17.
•    The stock’s 50-day moving average is $16 and its 200-day moving average is $13.
•    Boston Scientific’s market cap is $23.95 billion.

More articles on gastroenterology:
6 gastroenterologists making headlines – March 20, 2015
Morgan Stanley sets Boston Scientific price target at $20
AGA Diversity Committee expands sessions for DDW 2015

Advertisement

Next Up in GI & Endoscopy

Advertisement